文献速递类风湿关节炎系统性红斑狼疮

类风湿关节炎与系统性红斑狼疮患者的血清游离轻链及多配体蛋白聚糖-1水平

Serum levels of free light chains and syndecan-1 in patients with rheumatoid arthritis and systemic lupus erythematosus.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

本研究回顾性检测了60例类风湿关节炎、60例系统性红斑狼疮患者及50名健康供者的血清κ、λ游离轻链(浊度法)与多配体蛋白聚糖-1(SDC-1,ELISA)。结果显示两组患者SDC-1、κ-FLC、λ-FLC均显著高于健康供者,κ/λ比值组间无显著差异;SDC-1与游离轻链之间、各标志物与年龄或疾病活动度指数之间均未检出相关性。

要点

  • RA与SLE患者血清SDC-1、κ-FLC、λ-FLC均显著高于健康供者(P < 0.001)。
  • 三组间κ/λ比值无显著差异(P = 0.4)。
  • 各标志物与年龄、疾病活动度指数均未检出相关性。

核心结论

  • RA和SLE患者血清FLC与SDC-1水平较健康供者升高,提示其可能作为SARDs的生物标志物。
  • 研究结果提示存在持续的浆细胞活化,支持SDC-1在SARDs发病机制中的多重作用。

研究设计与样本

  • 回顾性分析,纳入60例类风湿关节炎患者、60例系统性红斑狼疮患者及50名健康供者(HD)。
  • κ-和λ-游离轻链采用浊度法测定,SDC-1采用ELISA测定。
  • 统计分析采用Kruskal-Wallis检验、Wilcoxon Mann-Whitney U检验、多变量线性回归和Spearman相关。

主要发现

  • SDC-1、κ-FLC和λ-FLC在RA和SLE患者中较HD显著升高(P < 0.001)。
  • κ/λ比值在各组间无显著差异(P = 0.4)。
  • 研究还发现受试者年龄存在显著差异,但多变量回归分析显示RA和SLE与这些标志物水平显著相关,年龄混杂影响很小。
  • 在各组内分别观察到FLC标志物之间存在显著相关性。
  • SDC-1与FLC之间未检出相关性,这些标志物与年龄或疾病活动度指数之间亦未检出相关性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Systemic autoimmune rheumatic diseases (SARDs) are characterized by chronic inflammation. Reliable biomarkers are crucial for diagnosis, monitoring disease progression and therapeutic responses. This study explores serum syndecan-1 (SDC-1) as a biomarker for these conditions and its relationship with free light chain (FLC) levels. METHODS: A retrospective analysis was performed on sera from 60 patients with rheumatoid arthritis (RA) and from 60 with systemic lupus erythematosus (SLE), alongside 50 healthy donors (HD). Κ- and λ- FLCs were determined by turbidimetric assay, while SDC-1 levels were determined by ELISA. Kruskal-Wallis test, Wilcoxon Mann-Whitney U test, multivariable linear regression and Spearman's correlation were employed to compare biomarker levels across groups and to explore correlations. RESULTS: SDC-1, κ-FLC and λ-FLC were significantly increased in RA and SLE patients compared with HD (P < 0.001), while no significant differences in the κ/λ ratio were observed among the groups (P = 0.4). A significant difference in subject age was also identified. However, multivariate regression analysis indicated that RA and SLE are significantly associated with the levels of these markers, with minimal confounding by age. A significant correlation was observed separately in all groups between the FLC markers. Conversely, no correlation was detected between SDC-1 and FLCs, nor between these markers and age or disease activity indices. CONCLUSION: Elevated serum levels of FLCs and SDC-1 in RA and SLE patients compared with HD underscore their potential as biomarkers for SARDs. The findings also suggest sustained plasma cell activation, supporting the multifaceted role of SDC-1 in the pathogenesis of SARDs.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Carnazzo V, Gulli F, Basile V, et al. Serum levels of free light chains and syndecan-1 in patients with rheumatoid arthritis and systemic lupus erythematosus. Rheumatology (Oxford). 2025. PMID: 39509329. doi:10.1093/rheumatology/keae623

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。